Rickets
10
0
0
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.0%
1 terminated out of 10 trials
85.7%
-0.8% vs benchmark
0%
0 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (10)
Specturi Device - Feasibility Study
The Impact of Phosphate Metabolism on Healthy Aging
Ultrasound Imaging and Quantitative Vibro-Acoustic Assessment of Rickets Under the Age of Ten
Studies of States With Resistance to Vitamin D and Parathyroid Hormone
Hypophosphatemic Rickets in Norway
Maternal and Infant Vitamin Status During the First Nine Months of Infant Life
Vitamin D, Iodine, and Lead Levels in Haitian Infants and Children.
Study to Assess the Use of a Simple Lab Test to Screen for Rickets in Children
Studies With 1,25-Dihydroxycholecalciferol
Vitamin D Supplementation in Breastfeeding Women